NFATC2IP and cardiac hypertrophy: Moreover, β‐Mhc, known as a biomarker of cardiac hypertrophy and reported to be involved in remodelling myocardiocytes in the early stage of overload pressure‐induced cardiac hypertrophy, was transactivated by Nfatc2ip binding to its core‐promoter.